#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13518	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2056	647.7	0	.	n	.	0	C451T	SNP	451	451	C	689	689	T	800	T,C,A	398,385,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13518	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2056	647.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	753	C,G	733,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13518	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2056	647.7	0	HET	.	.	.	C207T,G	.	207	207	C	445	445	C	786	C,T,G	579,174,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25802	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3553	719.7	0	.	n	.	0	T695C	SNP	695	695	T	1054	1054	C	794	C	772	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25802	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3553	719.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2330	2330	C	808	C	793	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25802	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3553	719.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2404	2404	A	847	A	833	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25802	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3553	719.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2956	2956	C	777	C,A	747,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25802	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3553	719.7	0	HET	.	.	.	A1638G	.	1638	1638	A	1997	1997	A	827	A,G	425,388	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	20	blaTEM	861	185	99.46	blaTEM.l15.c30.ctg.1	272	2.2	0	.	p	.	0	L247M	NONSYN	739	741	CTG	63	65	ATG	1;1;1	A,C;T;G	0,1;1;1	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1964	folP	855	855	100.0	folP.l15.c4.ctg.1	1567	124.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1076	1078	AGC	195;194;194	A;G;C	188;189;187	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5478	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3374	160.8	1	SNP	p	S91F	1	.	.	271	273	TTC	571	573	TTC	204;203;206	T;T;C	198;200;201	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5478	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3374	160.8	1	SNP	p	G95N	0	.	.	283	285	GGC	583	585	GGC	197;197;197	G;G,A;C	189;186,1;190	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5478	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3374	160.8	1	SNP	p	D95G	1	.	.	283	285	GGC	583	585	GGC	197;197;197	G;G,A;C	189;186,1;190	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1604	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1283	123.2	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	195;196;199	G,C;G,T,C;C	189,1;189,1,1;194	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	854	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	915	92.2	0	.	n	.	0	A197.	DEL	197	197	A	577	577	A	186	A	186	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3086	151.4	1	SNP	p	D86N	0	.	.	256	258	GAC	556	558	GAC	182;181;183	G;A;C	179;171;180	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3086	151.4	1	SNP	p	R87W	0	.	.	259	261	CGT	559	561	CGT	181;182;183	C;G;T,C	177;175;177,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3086	151.4	1	SNP	p	S87R	1	.	.	259	261	CGT	559	561	CGT	181;182;183	C;G;T,C	177;175;177,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3086	151.4	1	SNP	p	R87I	0	.	.	259	261	CGT	559	561	CGT	181;182;183	C;G;T,C	177;175;177,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3086	151.4	1	SNP	p	S88P	0	.	.	262	264	TCC	562	564	TCC	183;188;188	T,C;C;C	176,1;180;184	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4166	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2598	158.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	213;206;207	G;G;C	209;201;199	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1293	1295	GCC	189;194;193	G;C;C	183;188;189	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1296	1298	ATG	190;189;192	A;T;G	183;185;187	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1308	1310	ACC	201;200;199	A;C;C	194;193;194	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1308	1310	ACC	201;200;199	A;C;C	194;193;194	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1809	1811	ACC	194;197;197	A;C;C	187;193;194	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1863	1865	GCG	193;198;196	G;C;G,A	189;193;190,2	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1863	1865	GCG	193;198;196	G;C;G,A	189;193;190,2	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1986	1988	GGT	141;141;139	G,A;G;T,C	132,1;134;130,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1995	1997	AGC	129;129;126	A;G,A;C	120;123,1;124	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3732	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2453	151.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2013	2015	CCG	102;107;104	C,G;C,G;G	95,2;101,1;93	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5472	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3041	178.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1508	1510	CCG	185;187;186	C;C;G	173;181;177	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2432	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1830	131.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	591	591	C	169	C,G	156,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2702	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1498	176.8	1	SNP	p	G120K	1	.	.	358	360	AAG	678	680	AAG	239;242;244	A,G;A,G;G,A	225,2;235,1;223,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2702	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1498	176.8	1	SNP	p	N121D	0	.	.	361	363	AAC	681	683	AAC	241;239;238	A,G;A,C;C	229,1;233,1;224	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2702	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1498	176.8	1	SNP	p	A121N	1	.	.	361	363	AAC	681	683	AAC	241;239;238	A,G;A,C;C	229,1;233,1;224	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9290	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4786	192.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	974	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	920	104.3	1	SNP	p	V57M	1	.	.	169	171	ATG	504	506	ATG	207;207;209	A;T;G	205;205;207	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
